NO995681L - Fremgangsmåte for å fremstille fluorbiprofen-tabletter - Google Patents

Fremgangsmåte for å fremstille fluorbiprofen-tabletter

Info

Publication number
NO995681L
NO995681L NO995681A NO995681A NO995681L NO 995681 L NO995681 L NO 995681L NO 995681 A NO995681 A NO 995681A NO 995681 A NO995681 A NO 995681A NO 995681 L NO995681 L NO 995681L
Authority
NO
Norway
Prior art keywords
tablets
mixture
fluorobiprofen
preparing
forming
Prior art date
Application number
NO995681A
Other languages
English (en)
Norwegian (no)
Other versions
NO995681D0 (no
Inventor
Andrew Day
Huw Lyn Jones
Carl Simon Smith
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO995681L publication Critical patent/NO995681L/no
Publication of NO995681D0 publication Critical patent/NO995681D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO995681A 1997-05-22 1999-11-19 Fremgangsmåte for å fremstille fluorbiprofen-tabletter NO995681D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (2)

Publication Number Publication Date
NO995681L true NO995681L (no) 1999-11-19
NO995681D0 NO995681D0 (no) 1999-11-19

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995681A NO995681D0 (no) 1997-05-22 1999-11-19 Fremgangsmåte for å fremstille fluorbiprofen-tabletter

Country Status (31)

Country Link
US (1) US6194003B1 (enEXAMPLES)
EP (1) EP0983059B1 (enEXAMPLES)
JP (1) JP2001527567A (enEXAMPLES)
KR (1) KR20010012739A (enEXAMPLES)
CN (1) CN1154480C (enEXAMPLES)
AR (1) AR015812A1 (enEXAMPLES)
AT (1) ATE245021T1 (enEXAMPLES)
AU (1) AU725760B2 (enEXAMPLES)
BG (1) BG103881A (enEXAMPLES)
BR (1) BR9809651A (enEXAMPLES)
CA (1) CA2290830C (enEXAMPLES)
CZ (1) CZ290816B6 (enEXAMPLES)
DE (1) DE69816440T2 (enEXAMPLES)
DK (1) DK0983059T3 (enEXAMPLES)
ES (1) ES2202871T3 (enEXAMPLES)
GB (1) GB9710521D0 (enEXAMPLES)
HU (1) HU224954B1 (enEXAMPLES)
ID (1) ID22949A (enEXAMPLES)
IL (1) IL132999A0 (enEXAMPLES)
IN (1) IN187837B (enEXAMPLES)
MY (1) MY118410A (enEXAMPLES)
NO (1) NO995681D0 (enEXAMPLES)
NZ (1) NZ500664A (enEXAMPLES)
PL (1) PL190947B1 (enEXAMPLES)
PT (1) PT983059E (enEXAMPLES)
RU (1) RU2203046C2 (enEXAMPLES)
SK (1) SK283701B6 (enEXAMPLES)
TR (1) TR199902725T2 (enEXAMPLES)
UA (1) UA53714C2 (enEXAMPLES)
WO (1) WO1998052539A1 (enEXAMPLES)
ZA (1) ZA984260B (enEXAMPLES)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1235558E (pt) 1999-12-09 2006-09-29 Boots Co Plc Agentes terapeuticos
EP1284729A4 (en) * 2000-04-13 2007-12-19 Mayo Foundation A- (BETA) -42 DECREASING MEDICINAL PRODUCTS
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
JP2007528857A (ja) * 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
KR20070004036A (ko) * 2004-04-29 2007-01-05 키스톤 리테이닝 월 시스템스, 아이엔씨 벽, 옹벽 및 그 외 유사한 것을 위한 베니어
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
EA013867B1 (ru) 2005-02-03 2010-08-30 Никомед Фарма Ас Способ получения гранулята, содержащего карбонат кальция
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
JP2009502807A (ja) * 2005-07-22 2009-01-29 ミリアド ジェネティクス， インコーポレイテッド 薬剤含有率の高い製剤および投与量形態
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
MX2009010424A (es) * 2007-07-23 2009-10-20 Teikoku Pharma Usa Inc Formulaciones de dosificacion oral de agonista del receptor de serotina de indol organolepticamente aceptable y metodos para utilizar las mismas.
CN102131496B (zh) * 2008-08-22 2013-10-23 雷克特本克斯尔保健(英国)有限公司 组合物的改进或与组合物有关的改进
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
HUE053776T2 (hu) 2011-04-29 2021-07-28 Moberg Pharma Ab Gyógyszerészeti készítmény, amely helyi érzéstelenítõként bupivakaint tartalmaz szájban vagy torokban történõ helyi adagoláshoz
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
JP6315741B2 (ja) * 2015-08-18 2018-04-25 合同会社Ｐｈａｒｍａ Ｓｅｅｄｓ Ｃｒｅａｔｅ ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
TR199902725T2 (xx) 2000-02-21
BG103881A (bg) 2000-05-31
DE69816440T2 (de) 2004-05-13
ID22949A (id) 1999-12-16
DE69816440D1 (de) 2003-08-21
SK283701B6 (sk) 2003-12-02
GB9710521D0 (en) 1997-07-16
JP2001527567A (ja) 2001-12-25
BR9809651A (pt) 2000-07-11
HUP0002121A3 (en) 2001-04-28
US6194003B1 (en) 2001-02-27
CZ290816B6 (cs) 2002-10-16
PT983059E (pt) 2003-11-28
AU725760B2 (en) 2000-10-19
DK0983059T3 (da) 2003-11-03
MY118410A (en) 2004-10-30
ATE245021T1 (de) 2003-08-15
CA2290830C (en) 2006-07-11
ES2202871T3 (es) 2004-04-01
CN1255848A (zh) 2000-06-07
IL132999A0 (en) 2001-03-19
EP0983059B1 (en) 2003-07-16
RU2203046C2 (ru) 2003-04-27
HU224954B1 (en) 2006-04-28
KR20010012739A (ko) 2001-02-26
CZ412099A3 (cs) 2000-02-16
IN187837B (enEXAMPLES) 2002-06-29
UA53714C2 (uk) 2003-02-17
SK158899A3 (en) 2000-05-16
CN1154480C (zh) 2004-06-23
AU7916598A (en) 1998-12-11
NO995681D0 (no) 1999-11-19
PL190947B1 (pl) 2006-02-28
CA2290830A1 (en) 1998-11-26
EP0983059A1 (en) 2000-03-08
WO1998052539A1 (en) 1998-11-26
ZA984260B (en) 1999-02-20
AR015812A1 (es) 2001-05-30
HUP0002121A2 (hu) 2000-12-28
NZ500664A (en) 2001-01-26
PL336624A1 (en) 2000-07-03

Similar Documents

Publication Publication Date Title
NO995681L (no) Fremgangsmåte for å fremstille fluorbiprofen-tabletter
CA2225286A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
DE2966767D1 (en) Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them
AU7061587A (en) Controlled-release pharmaceutical composition for periodontal diseases
PT81007A (en) Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same
ES8602599A1 (es) Un procedimiento de preparar un derivado de trans-1,2-diaminoxiclohexil-amida.
IE821861L (en) Pharmaceutical compositions
IL112957A0 (en) Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them
GEP20033062B (en) Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative
DE3263567D1 (en) New compounds with antiinflammatory and antitussive activity, process for their preparation and relative pharmaceutical compositions
DK136487A (da) Farmaceutisk praeparat indeholdende ibuprofen og fremgangsmaade til fremstilling deraf
EP0295212A3 (en) Process for preparing a pharmaceutical composition
HUT48232A (en) Process for producing new biphenyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DE2966706D1 (en) Substituted anthranilic acid amides, process for their preparation, pharmaceutical compositions containing them and their preparation
AU7292794A (en) A method of manufacturing a laxative composition dosage unit and dosage units obtained thereby
PT74937A (en) Process for the preparation of novel analgesic and antiinflammatory compounds and of pharmaceutical compositions containing the same
ES8504166A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz(b,e) oxepina.
KR890007745A (ko) 약학조성물 및 그의 제조방법
ES8506717A1 (es) Procedimiento de preparacion de nuevos derivados de 1, 3-dihidro-6-metil-7-hidroxi-furo-(3, 4-c)-piridina
HU175413B (hu) Sposob poluchenija zamehhennykh proizvodnykh indola i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
FR2769839B1 (fr) Composition anhydre a base de lactulose
DE3269449D1 (en) P-acylaminophenol derivatives with a therapeutical effect, process for their preparation, and compositions with a therapeutical effect containing these derivatives as pharmacologically active ingredients
HUT34489A (en) Process for preparing 7-oxo-4-thia-1-aza-bicyclo/3,2,0/hept-2-ene derivatives and pharmaceutical compositions containing thereof as active substances
KR890001559A (ko) 트라피딜을 함유하는 제약 조성물, 그의 제조방법 및 관련된 치료 용도
DE69102143D1 (de) Spiramycin enthaltende arzneimittel und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application